S&D Co., Ltd (KOSDAQ:260970)

Market Cap	190.92B
Revenue (ttm)	147.51B
Net Income (ttm)	20.10B
Shares Out	2.89M
EPS (ttm)	6,948.13
PE Ratio	9.50
Forward PE	6.59
Dividend	800.00 (1.21%)
Ex-Dividend Date	Dec 29, 2025

Volume	17,643
Average Volume	45,544
Open	65,100
Previous Close	65,300
Day's Range	64,700 - 66,600
52-Week Range	40,150 - 149,800
Beta	0.90
RSI	43.09
Earnings Date	Mar 13, 2026

About S&D Co., Ltd

S&D Co., Ltd develops and sells health functional food in South Korea. The company offers general functional food ingredients, health-oriented functional ingredients, and biological industry materials for the sleeping problems and glycoconjugate gastric functions. It provides health-oriented functional ingredients, such as Lindera glauca extract, Rice bran Extract, MPG-6/MPGT, RCS, and Xanthorrhizol, as well as other materials, including Pagopyridol, SD 1002F, and Panduratin. The company also offers general functional food ingredients comprisin...

• Industry: Miscellaneous Food Preparations And Kindred Products
• Founded: 1998
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 260970

Financial Performance

In 2024, S&D Co., Ltd's revenue was 116.14 billion, an increase of 31.56% compared to the previous year's 88.28 billion. Earnings were 17.03 billion, an increase of 43.45%.